M D Adelman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M D Adelman

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Annals of Internal Medicine|August 15, 1997

Warfarin: less may be betterM D Adelman

JAMA|June 8, 1999

Glycemic control and quality of life in patients with type 2 diabetesM D Adelman

The New England Journal of Medicine|January 10, 1998

Low-molecular-weight heparin versus unfractionated heparin for unstable coronary diseaseB A Baker, M D Adelman

Archives of Internal Medicine|December 31, 1997

Inability of the activated partial thromboplastin time to predict heparin levels. Time to reassess guidelines for heparin assaysB A Baker, M D Adelman, P A Smith, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Annals of Internal Medicine|August 15, 1997

Warfarin: less may be betterM D Adelman

JAMA|June 8, 1999

Glycemic control and quality of life in patients with type 2 diabetesM D Adelman

The New England Journal of Medicine|January 10, 1998

Low-molecular-weight heparin versus unfractionated heparin for unstable coronary diseaseB A Baker, M D Adelman

Archives of Internal Medicine|December 31, 1997

Inability of the activated partial thromboplastin time to predict heparin levels. Time to reassess guidelines for heparin assaysB A Baker, M D Adelman, P A Smith, et al.

Pageof 1